樂
樂觀
樂觀 · 25%NIVF
$0.57
情境價格
$0.450
-0.034 (-7.61%)收盤時
Loading chart…
- 最高
- 0.493
- 開盤
- 0.493
- 成交量加權均價
- 0.46
- 成交量
- 78.02K
- 市值
- —
- 最低
- 0.450
- 成交金額
- 36.22K
- 企業價值/稅息折舊攤銷前利潤（TTM）
- -0.02
NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia.
AI 分析 of NewGenIvf Group Ltd (NIVF)
賣出NIVF is not a good buy right now due to its extremely low price of $0.45, a staggering year-to-date change of -99.98%, and a very low RSI of 15.207, indicating oversold conditions. The stock has also seen a 5-day change of -54.06%, suggesting a strong downward trend. The main risk is the company's recent public offering, which has caused further declines in stock price, and the uncertainty surrounding its financial stability, as evidenced by a forward P/E of 0.0015, indicating potential earnings issues.
估值指標
NewGenIvf Group Ltd（NIVF）目前預期本益比為 0.00，5 年平均預期本益比為 0.07。
Alphio AI 對 NIVF 的價格情境
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重（25 / 50 / 25），不構成保證。
事件時間軸
資訊
8.509-29NASDAQ.COMNewGen IVF Group Sets Pricing for Public Offering
8.508-17NewsfilterNewGenIVF Completes Convertible Note Exchange Agreement
- 8.507-30Newsfilter
NewGen's Investment in K25.ai Shows Significant Appreciation
8.507-27seekingalphaNewGen Acquires Additional 3% Stake in K25.ai, Raising Ownership to 13%
8.507-27GlobenewswireNewGenIVF Acquires Additional Stake in K25.ai
NIVF 常見問題 —— 由 Alphio AI 解答
NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia. It operates in the Healthcare sector.
NIVF is not a good buy right now due to its extremely low price of $0.45, a staggering year-to-date change of -99.98%, and a very low RSI of 15.207, indicating oversold conditions. The stock has also seen a 5-day change of -54.06%, suggesting a strong downward trend. The main risk is the company's recent public offering, which has caused further declines in stock price, and the uncertainty surrounding its financial stability, as evidenced by a forward P/E of 0.0015, indicating potential earnings issues.
社群
更多 ↗暫無貼文
註冊或登入後參與討論相關文章
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。